Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval
Links shared publicly online about this topic.
- 1,245total visits
Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP, (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline's antidepressant Wellbutrin SR®.
View full resource at news-medical.net
Tags: Antidepressant, Drug, Pharma, Smoking Cessation Medication, FDA, Wellbutrin, Zyban, GlaxoSmithKline
Most Recently Shared on April 12, 2010 at 5:26 pm By:
Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval: Mylan Inc. today announced that... http://bit.ly/cAMf63
Advertisement
